Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2025 05:28 ET | Source: Research and Markets

2025 Anti-CD38 Antibody Pipeline Insights for 10+ Companies and 12+ Pipeline Drugs, Including Felzartamab (I-MAB Biopharma), TAK-079 (Takeda), and ISB 1342 (Ichnos Sciences)

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Anti-CD38 Antibody - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
October 24, 2024 10:15 ET | Source: Research and Markets

Mesothelin-Targeted Immunotherapy Pipeline Market Review 2024: Drug Code/INN, Target(s)/MoA, Class of Compound, Territory of Main Competitor, Indication(s) & R&D Stage

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
May 28, 2024 09:06 ET | Source: Research and Markets

World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years

Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
April 26, 2024 04:12 ET | Source: Research and Markets

NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)

Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "NK Cell Therapies - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
January 23, 2024 09:43 ET | Source: Research and Markets

Tumor Infiltrating Lymphocytes Industry Projected to Reach $18.32 Billion by 2028 - Emerging Technologies, such as cytoDRIVE, and Strategic Alliances Propelling the Global Market Forward

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Growth Driven by...
January 03, 2024 11:33 ET | Source: Research and Markets

Global Natural Killer Cells Therapeutics Research Report 2023: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2022 and 2023-2028

Dublin, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The "Global Natural Killer Cells Therapeutics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
December 14, 2023 05:43 ET | Source: Research and Markets

Immunotherapy Targeting Mesothelin: A Comprehensive 2023 Pipeline Review

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Mesothelin-Targeted Immunotherapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. A groundbreaking review of...
August 07, 2023 06:03 ET | Source: Research and Markets

Natural Killer Cells Therapeutics Market Analysis and Industry Forecast to 2027: Advancements in Manufacturing Processes, Cell Engineering Techniques and Development of Combination Therapies

Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Natural Killer Cells Therapeutics Market by Therapeutics, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2027" report...
July 14, 2023 04:53 ET | Source: Research and Markets

Global Web Analytics Market to Reach $13.92 Billion by 2027, Driven by Growing Demand for Online Shopping and Technological Advancements

Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The "Urothelial Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global web analytics market is...
May 23, 2023 04:53 ET | Source: Research and Markets

Tumor Infiltrating Lymphocytes Global Market Report 2023: Sector to Reach $15.56 Billion by 2027 at a 13.7% CAGR

Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tumor infiltrating...

Next Page keyboard_arrow_right